Adagio Medical Holdings Statistics
Total Valuation
ADGM has a market cap or net worth of $45.79 million. The enterprise value is $179.38 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADGM has 13.39 million shares outstanding. The number of shares has increased by 2.49% in one year.
| Shares Outstanding | 13.39M |
| Shares Change (YoY) | +2.49% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 12.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.12 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 449.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $4,694 |
| Profits Per Employee | -$409,412 |
| Employee Count | 85 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.03 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 26.22 |
| Average Volume (20 Days) | 23,439 |
Short Selling Information
The latest short interest is 50,001, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 50,001 |
| Short Previous Month | 1 |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.41% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
In the last 12 months, ADGM had revenue of $399,000 and -$34.80 million in losses. Loss per share was -$45.18.
| Revenue | 399,000 |
| Gross Profit | -1.41M |
| Operating Income | -29.89M |
| Pretax Income | n/a |
| Net Income | -34.80M |
| EBITDA | -29.03M |
| EBIT | -29.89M |
| Loss Per Share | -$45.18 |
Full Income StatementBalance Sheet
The company has $2.05 million in cash and $52.21 million in debt, giving a net cash position of -$50.16 million or -$3.75 per share.
| Cash & Cash Equivalents | 2.05M |
| Total Debt | 52.21M |
| Net Cash | -50.16M |
| Net Cash Per Share | -$3.75 |
| Equity (Book Value) | -56.71M |
| Book Value Per Share | -183.93 |
| Working Capital | -58.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$27.17 million and capital expenditures -$475,000, giving a free cash flow of -$27.65 million.
| Operating Cash Flow | -27.17M |
| Capital Expenditures | -475,000 |
| Free Cash Flow | -27.65M |
| FCF Per Share | -$2.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -7,490.73% |
| Pretax Margin | -8,721.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |